AI assistant
Sending…
Phathom Pharmaceuticals, Inc. — Director's Dealing 2022
Feb 19, 2022
32407_dirs_2022-02-18_86bbcba0-a07e-4187-87a5-f022fb8c66a5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Phathom Pharmaceuticals, Inc. (PHAT)
CIK: 0001783183
Period of Report: 2019-10-29
Reporting Person: COLA MICHAEL F (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-10-29 | Common Stock | P | 9798 | $19.00 | Acquired | 9798 | Direct |
More from Phathom Pharmaceuticals, Inc.
Regulatory Filings
2026
May 21
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Regulatory Filings
2026
Mar 27
Director's Dealing
2026
Mar 3
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 12